moxifloxacin has been researched along with acriflavine chloride in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (acriflavine chloride) | Trials (acriflavine chloride) | Recent Studies (post-2010) (acriflavine chloride) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 19 | 0 | 7 |
| Protein | Taxonomy | moxifloxacin (IC50) | acriflavine chloride (IC50) |
|---|---|---|---|
| rac GTPase-activating protein 1 isoform a | Homo sapiens (human) | 78.3 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 4.98 | |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 1 | |
| putative polyprotein | 3.141 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, Y; Kato, H; Kimura, K; Konda, T; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
1 other study(ies) available for moxifloxacin and acriflavine chloride
| Article | Year |
|---|---|
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chitosan; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Malates; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Uncoupling Agents | 2007 |